9.7 Interprofessional Care Coordination for Sterile Preparations

9.7 Interprofessional Care Coordination for Sterile Preparations

No compounding pharmacist works alone. A CSP passes through a prescriber's order, a pharmacist's verification, a technician's hands, a delivery system, a nurse's pump and a patient's vein, and then back through monitoring. The BCSCP outline lists interprofessional care coordination (task 2A4) because most serious CSP errors happen at handoffs between people and teams.

The teams and what each needs from sterile compounding

Aligning practice across disciplines

• P&T committee: Approves formulary products, standard concentrations and protocols so that orders, labels, pump libraries and compounding recipes match.
• Standardize 4 Safety: ASHP's initiative publishes national standard concentrations for adult and pediatric continuous infusions and compounded oral liquids. Adopting them reduces confusion when patients move between facilities.
• Oncology safety standards: The ASCO/ONS antineoplastic therapy administration safety standards call for independent verification of chemotherapy orders by two qualified practitioners before preparation, and again at administration.
• Antimicrobial stewardship: The CMS hospital Conditions of Participation (42 CFR 482.42) require an antibiotic stewardship program alongside infection prevention. Pharmacists typically lead day-to-day review.

Transitions: hospital to home infusion

Common failure points include:

• a first dose scheduled for home before any dose has been tolerated in a monitored setting;
• laboratory orders with no named clinician to review the results;
• a device or concentration that differs between hospital and home;
• missing stability data for the home delivery interval.

The IDSA's OPAT practice guideline covers patient selection, monitoring and team roles for outpatient antimicrobial therapy.

Communication tools

• SBAR (Situation, Background, Assessment, Recommendation) for pharmacist-to-prescriber calls about a CSP problem.
• Closed-loop communication: The receiver repeats the key details back (drug, dose, concentration, route), and the sender confirms.
• Daily huddles in the IV room, and shared dashboards for turnaround, environmental excursions and shortages.
• Written handoffs for shift changes and for patients moving between settings, listing active infusions, concentrations and BUDs.

Data sharing that improves outcomes

• Share environmental monitoring and personnel competency trends with infection prevention, so that CLABSI clusters can be reviewed alongside compounding data.
• Share near misses caught by workflow technology (wrong vial, wrong diluent) with the medication safety committee, to redesign storage, look-alike labeling or order sets.
• Share shortage status early with prescribers and nurses, with alternatives and conversion guidance already prepared.

Coordinating around shortages, recalls and protocols

• Shortages: A shortage team of pharmacy, prescribers, nursing and supply chain agrees on substitutes, concentration changes and conservation rules. It then updates order sets, pump libraries and compounding recipes together, so that no single step is left behind.
• Recalls and quality alerts: When a CSP or a component is recalled, the pharmacy tells the units, removes stock, identifies patients who received the product, and works with prescribers on monitoring (see 12.2). Infection prevention joins when contamination is possible.
• Protocols and collaborative practice: Where state law and the medical staff allow, pharmacists manage parenteral nutrition, aminoglycoside and vancomycin dosing, and electrolyte replacement under approved protocols. They order laboratory tests and adjust therapy within set limits, and they document their communication with the team.
• Pharmacy technicians: Certified technicians (for example with a compounded sterile preparation technician credential) are core team members. Clear delegation, competency records and escalation paths let pharmacists focus on verification and clinical review.